September 22, 2014
WASHINGTON (AP) - DNA may be the building block of life, but can something taken from it also be the building block of a multimillion-dollar medical monopoly?
The Supreme Court grapples Monday with the question of whether human genes can be patented. Its ultimate answer could reshape U.S. medical research, the fight against diseases like breast and ovarian cancer and the multi-billion dollar medical and biotechnology business.
The U.S. Patent and Trademark Office has been awarding patents on human genes for almost 30 years.
Companies like Myriad Genetics say they have risked billions of dollars to conduct research under the promise of such patents. The American Civil Liberties Union has challenged Myriad's patents, arguing that genes should never have been patented in the first place.
Copyright 2014 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.